Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ENTERA BIO LTD SHS ENTX | RA CAPITAL MANAGEMENT L.P. | 295,966 1.000% | -2,057,034 (-87.42%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IO BIOTECH INC IOBTQ | RA CAPITAL MANAGEMENT L.P. | 1,127,260 3.900% | -730,495 (-39.32%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | INSTIL BIO INC TIL | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -383,540 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 7,691,990 9.990% | -41,086,182 (-84.23%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA CAPITAL MANAGEMENT L.P. | 7,040,622 9.600% | 2,075,034 (+41.79%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.200% | -1,629,747 (-29.03%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | IMARA INC IMRA | RA CAPITAL MANAGEMENT L.P. | 3,250,724 12.400% | 29,899 (+0.93%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | TENAYA THERAPEUTICS INC TNYA | RA CAPITAL MANAGEMENT L.P. | 6,428,483 9.990% | 2,876,975 (+81.01%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | GERON CORP GERN | RA CAPITAL MANAGEMENT L.P. | 48,423,211 9.990% | 16,034,412 (+49.51%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,246,503 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,282,173 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PHASEBIO PHARMACEUTICALS INC C PHASQ | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,850,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | RA CAPITAL MANAGEMENT L.P. | 143,900 0.300% | -3,373,794 (-95.91%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | VERA THERAPEUTICS INC VERA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | BCLS ACQUISITION CORP BLSA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,250,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | HILLEVAX INC HLVX | RA CAPITAL MANAGEMENT L.P. | 1,760,019 5.300% | 1,760,019 (New Position) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | ORCHESTRA BIOMED HOLDINGS, INC OBIO | RA CAPITAL MANAGEMENT L.P. | 610,283 5.400% | 610,283 (New Position) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | RA CAPITAL MANAGEMENT L.P. | 4,397,368 9.600% | 40,736 (+0.94%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | RA CAPITAL MANAGEMENT L.P. | 3,773,517 19.500% | 106,854 (+2.91%) | Filing History |